Patents Assigned to Children's Medical Center Corporation Dana-Farber Cancer Institute
  • Compositions and methods for inhibiting viral entry
    Patent number: 11116818
    Abstract: The invention provides methods, compositions, and kits featuring agents that inhibit viral entry mediated by T-cell Immunoglobulin and Mucin-domain containing proteins (TIM proteins) and other phosphatidylserine receptors.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: September 14, 2021
    Assignee: Children's Medical Center Corporation Dana-Farber Cancer Institute
    Inventors: Hyeryun Choe, Stephanie Jemielity, Dale T. Umetsu, Rosemarie H. De Kruyff, Gordon J. Freeman